Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Amicus Therapeutics (FOLD) over the last 17 years, with Q3 2025 value amounting to 0.27.

  • Amicus Therapeutics' Equity Ratio rose 1665.53% to 0.27 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.27, marking a year-over-year increase of 1665.53%. This contributed to the annual value of 0.25 for FY2024, which is 2004.25% up from last year.
  • Amicus Therapeutics' Equity Ratio amounted to 0.27 in Q3 2025, which was up 1665.53% from 0.25 recorded in Q2 2025.
  • In the past 5 years, Amicus Therapeutics' Equity Ratio registered a high of 0.39 during Q3 2021, and its lowest value of 0.15 during Q1 2023.
  • Moreover, its 5-year median value for Equity Ratio was 0.23 (2024), whereas its average is 0.23.
  • In the last 5 years, Amicus Therapeutics' Equity Ratio crashed by 5566.61% in 2022 and then soared by 4171.93% in 2025.
  • Over the past 5 years, Amicus Therapeutics' Equity Ratio (Quarter) stood at 0.34 in 2021, then plummeted by 49.96% to 0.17 in 2022, then increased by 21.18% to 0.21 in 2023, then increased by 20.04% to 0.25 in 2024, then rose by 7.3% to 0.27 in 2025.
  • Its Equity Ratio was 0.27 in Q3 2025, compared to 0.25 in Q2 2025 and 0.25 in Q1 2025.